Glaxosmithkline Pharmaceuticals Q3 Results
- BSE: 500660
- NSE: GLAXO
- ISIN: INE159A01016
- Sector: Biotechnology & Drugs
BSE
2,345.9
-69.30 (-2.87%)
-69.30 (-2.87%)Volume4.41 K
Updated: Mon 25 Nov, 2024 | 15:40:02
NSE
2,341.65-70.15 (-2.91%)
-70.15 (-2.91%)Volume1.12 L
Updated: Mon 25 Nov, 2024 | 15:43:58
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Glaxosmithkline Pharmaceuticals Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 23 | Sep 23 | QoQ Comp | Dec 22 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 805.26 | 956.99 | -% | 802.30 | -% |
| Selling/ General/ Admin Expenses Total | 141.35 | 145.21 | -% | 152.99 | -% |
| Depreciation/ Amortization | 17.11 | 18.11 | -% | 16.41 | -% |
| Other Operating Expenses Total | 129.01 | 167.85 | -% | 132.53 | -% |
| Total Operating Expense | 767.62 | 685.61 | -% | 601.38 | -% |
| Operating Income | 37.64 | 271.38 | -% | 200.92 | -% |
| Net Income Before Taxes | 65.43 | 299.16 | -% | 224.25 | -% |
| Net Income | 45.72 | 217.51 | -% | 164.56 | -% |
| Diluted Normalized EPS | 9.44 | 12.84 | -% | 10.20 | -% |
EQUITY QUICK LINKS
FROM MARKETS
RELATED LINKS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST